Why is Strides Pharma falling/rising?

As of 07-Aug, Strides Pharma Science Ltd is experiencing a decline in its stock price, currently at Rs 796.00, which reflects a decrease of Rs 9.65 or 1.2%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 5.07% during this period. Additionally, the stock has underperformed its sector by 1.85% today. The stock's performance over the past week shows a significant drop of 8.59%, while its one-month return is also negative at -8.40%. Despite these recent declines, the stock has shown strong performance year-to-date with a gain of 21.05% and an impressive 49.48% increase over the past year. However, the falling investor participation, indicated by a 72.57% drop in delivery volume compared to the five-day average, suggests a lack of confidence among investors. Broader Market Context: In comparison to the benchmark Sensex, which has declined by only 0.69% over the past week, Strides Pharma's performance has been notably worse. The Sensex has also shown a decline of 3.38% over the past month, indicating that the broader market is facing challenges as well. However, Strides Pharma's significant drop in stock price relative to the benchmark highlights specific issues affecting the company, such as its recent consecutive losses and lower trading volumes, which may be contributing to the negative sentiment surrounding its stock.